Researchers have created an up-to-date detailed molecular map of eye with vision loss disease.
Researchers from University of Iowa developed a most detailed map to date of the abundance of thousands of proteins in the choroid, a region of the human eye long associated with blinding diseases. By seeing differences in protein abundance, the researchers would begin to figure out which proteins might be the critical actors in vision loss and eye disease.
Vinit Mahajan, assistant professor in ophthalmology at the UI, said that this molecular map now gives them clues why certain areas of the choroid are more sensitive to certain diseases, as well as where to target therapies and why.
Jessica Skeie, a post-doctoral researcher in ophthalmology at the UI, said that they were able to identify thousands of proteins simultaneously and develop a map that shows the patterns of proteins that make these regions unique, furthermore this has helped them explain why certain genes are associated with macular degeneration, and helps point them to new treatment targets.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
